Masimo (MASI) Net Income towards Common Stockholders Growth (1y) (2010 - 2026)
Masimo (MASI) Net Income towards Common Stockholders Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 98.96% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -30.10% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.60% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 89.28% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn | 100.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 100.37% |
| Jan 3, 2026 | 102.25% |
| Sep 27, 2025 | -962.76% |
| Jun 28, 2025 | 172.73% |
| Mar 29, 2025 | -1,550.76% |
| Dec 28, 2024 | -573.54% |
| Sep 28, 2024 | -236.79% |
| Jun 29, 2024 | -156.05% |
| Mar 30, 2024 | -161.97% |
| Dec 30, 2023 | 46.94% |
| Sep 30, 2023 | -72.03% |
| Jul 1, 2023 | -13.26% |
| Apr 1, 2023 | -54.29% |
| Dec 31, 2022 | -31.80% |
| Oct 1, 2022 | -34.43% |
| Jul 2, 2022 | -63.94% |
| Apr 2, 2022 | -12.71% |
| Jan 1, 2022 | -7.62% |
| Oct 2, 2021 | 16.99% |
| Jul 3, 2021 | -9.99% |